10:06 AM EST - Pacgen Biopharmaceuticals Corp. : reported third quarter net loss of $468,000 or $0.01 per share, compared to a net loss of $22,000or breakeven per share last year. On a year-to-date basis, the company recorded a net loss of $1.11 million or $0.03 per share, compared to a net loss of $1.97 million or $0.06 per share for the same period in the preceding fiscal year. Pacgen Biopharmaceuticals Corp.
shares V.PGA are trading even at $0.03.
